EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro

Ioannis K Koutsaliaris iD, Despoina Pantazi iD, Aikaterini N Tsouka iD, Ourania Argyropoulou, Constantinos C Tellis, Alexandros D Tselepis iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251810136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ioannis K Koutsaliaris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Atherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, 45100 Ioannina, Greece. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, P-Selectin, Fatty Acids, Omega-3, Blood Platelets. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The omega-3 polyunsaturated fatty acids (PUFAs) Docosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA) exert multiple cardioprotective effects, influencing inflammation, platelet activation, endothelial function and lipid metabolism, besides their well-established triglyceride lowering properties. It is not uncommon for omega-3 PUFAs to be prescribed for hypertriglyceridemia, alongside antiplatelet therapy in cardiovascular disease (CVD) patients. In this regard, we studied the effect of EPA and DHA, in combination with antiplatelet drugs, in platelet aggregation and P-selectin and αIIbβ3 membrane expression. The antiplatelet drugs aspirin and triflusal, inhibitors of cyclooxygenase-1 (COX-1); ticagrelor, an inhibitor of the receptor P2Y12; vorapaxar, an inhibitor of the PAR-1 receptor, were combined with DHA or EPA and evaluated against in vitro platelet aggregation induced by agonists arachidonic acid (AA), adenosine diphosphate (ADP) and TRAP-6. We further investigated procaspase-activating compound 1 (PAC-1) binding and P-selectin membrane expression in platelets stimulated with ADP and TRAP-6. Both DHA and EPA displayed a dose-dependent inhibitory effect on platelet aggregation induced by AA, ADP and TRAP-6. In platelet aggregation induced by AA, DHA significantly improved acetylsalicylic acid (ASA) and triflusal’s inhibitory activity, while EPA enhanced the inhibitory effect of ASA. In combination with EPA, ASA and ticagrelor expressed an increased inhibitory effect towards ADP-induced platelet activation. Both fatty acids could not improve the inhibitory effect of vorapaxar on AA- and ADP-induced platelet aggregation. In the presence of EPA, all antiplatelet drugs displayed a stronger inhibitory effect towards TRAP-6-induced platelet activation. Both omega-3 PUFAs inhibited the membrane expression of αIIbβ3, though they had no effect on P-selectin expression induced by ADP or TRAP-6. The antiplatelet drugs exhibited heterogeneity regarding their effect on P-selectin and αIIbβ3 membrane expression, while both omega-3 PUFAs inhibited the membrane expression of αIIbβ3, though had no effect on P-selectin expression induced by ADP or TRAP-6. The combinatory effect of DHA and EPA with the antiplatelet drugs did not result in enhanced inhibitory activity compared to the sum of the individual effects of each component.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsP-SelectinFatty Acids, Omega-3Blood PlateletsPlatelet AggregationHumansDocosahexaenoic AcidsEicosapentaenoic AcidAspirinTicagrelorPlatelet Glycoprotein GPIIb-IIIa ComplexArachidonic AcidAdenosine DiphosphateLactonesPyridines

Stichwörter der Autor:innen

DHAEPAPUFAsantiplatelet drugsomega-3 fatty acidsplatelets

Substanzen

Platelet Aggregation InhibitorsP-SelectinFatty Acids, Omega-3Docosahexaenoic AcidsEicosapentaenoic AcidAspirinTicagrelorPlatelet Glycoprotein GPIIb-IIIa ComplexvorapaxarArachidonic Acid

Autor:innen und Institutionen

  • Atherothrombosis Research Centre/Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, 45100 Ioannina, Greece.

ORCID-Profile: Ioannis K Koutsaliaris, Despoina Pantazi, Aikaterini N Tsouka, Alexandros D Tselepis

Zitieren

APA

Koutsaliaris, I. K., Pantazi, D., Tsouka, A. N., Argyropoulou, O., Tellis, C. C., & Tselepis, A. D. (2024). Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810136

Vancouver

Koutsaliaris IK, Pantazi D, Tsouka AN, Argyropoulou O, Tellis CC, Tselepis AD. Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810136

BibTeX
@article{Koutsaliaris2024,
  author = {Koutsaliaris, Ioannis K and Pantazi, Despoina and Tsouka, Aikaterini N and Argyropoulou, Ourania and Tellis, Constantinos C and Tselepis, Alexandros D},
  title = {Differential Effect of Omega-3 Fatty Acids on Platelet Inhibition by Antiplatelet Drugs In Vitro},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251810136}
}
Kostenlos starten →